Ana Paula Ribeiro, MD
- Assistant Professor, CWRU School of Medicine
- Specialty: Neonatology
Biography: Ana Paula Ribeiro, MD
Certifications & Memberships
- Neonatal/Perinatal Medicine - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Education
Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Uh Cleveland Medical Center (2010 - 2013)
Residency | Pediatrics
Pediatrics - Jackson Memorial Hospital/Jackson Health System (2007 - 2010)
Medical Education
Universidade Federal Da Bahia (2006)
About
Ana Ribeiro, MD, FAAP, is a member of the neonatology residency education committee and a liaison of the Neonatal Parent and Family Advisory Council. She also is Associate Professor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Ribeiro is board certified in pediatrics and has a special interest in medical care of the newborn. She an instructor for the neonatology resuscitation program (NRP) and is certified in extra-corporeal membrane oxygenation (ECMO). Her research interests include medical education and quality improvement in the delivery room as well as prevention of bronchopulmonary dysplasia (BPD).
She earned her medical degree from Universidade Federal da Bahia, Bahia, Brazil. She completed a pediatrics residency at Jackson Memorial Hospital, University of Miami, and a neonatal-perinatal medicine fellowship at UH Rainbow Babies & Children’s Hospital in 2013.
Dr. Ribeiro was appointed to the UH Rainbow Babies & Children’s Hospital staff in 2017. Prior to that she was an attending physician at Hospital Alianca for three years in her hometown in Brazil.
Dr. Ribeiro is a Fellow of the American Academy of Pediatrics.
Awards and Recognitions
Fellow, American Academy of Pediatrics
Research & Publications
Research Interests
Resuscitation in the delivery room, medical education, quality improvement, and family centered care
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Ana Paula Ribeiro did not disclose any Outside Relationships with Industry.